HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals

Arthritis and Rheumatism

Volumn 48, Issue 9, 2003, Pages 2567-2572

  Artlett, Carol M ^a,f   O'Hanlon, Terrence P ^b,c,d   Lopez, Ana M ^a   Song, Yeong Wook ^e   Miller, Frederick W ^b,c,d   Rider, Lisa G ^b,c,d  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e Seoul National University Hospital   (South Korea)

^f Division of Rheumatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CONTROLLED STUDY; DNA ISOLATION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MICROCHIMERISM; MYOPATHY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC SCLEROSIS; T LYMPHOCYTE; Y CHROMOSOME;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHIMERA; CHROMOSOMES, HUMAN, Y; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ ANTIGENS; HUMANS; MALE; MATERNAL-FETAL EXCHANGE; MIDDLE AGED; MYOSITIS; PREGNANCY; RISK FACTORS; SCLERODERMA, SYSTEMIC; T-LYMPHOCYTES;

EID: 0141676370     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11235     Document Type: Article

References (19)

1. Artlett CM, Smith JB, Jimenez SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998;338:1186-91.
2. Artlett CM, Ramos R, Jimenez SA, Patterson K, Miller FW, Rider LG. Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Lancet 2000;356:2155-6.
3. Reed AM, Picornell YJ, Harwood A, Kredich D. Chimerism in children with juvenile dermatomyositis. Lancet 2000;356:2156-7.
4. Black CM, Briggs DC, Welsh KI. The immunogenetic background of scleroderma: an overview. Clin Exp Dermatol 1992;17:73-8.
5. Lambert NC, Distler O, Müller-Ladner U, Tylee TS, Furst DE, Nelson JL. HLA-DQA1*0501 is associated with diffuse systemic sclerosis in Caucasian men. Arthritis Rheum 2000;43:2005-10.
6. Artlett CM, Welsh KI, Black CM, Jimenez SA. Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis. Immunogenetics 1997;47:17-22.
7. Reed AM, Stirling JD. Association of the HLA-DQA1*0501 allele in multiple racial groups with juvenile dermatomyositis. Hum Immunol 1995;44:131-5.
8. Arnett FC, Targoff IN, Mimori T, Goldstein R, Warner NB, Reveille JD. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum 1996;39:1507-18.
9. Lambert NC, Evans PC, Hashizumi TL, Maloney S, Gooley T, Furst DE, et al. Persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity. J Immunol 2000;164:5545-8.
10. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 1988;15:202-5.
11. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7.
12. Artlett CM, Cox LA, Ramos RC, Dennis TN, Fortunato RA, Hummers LK, et al. Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosis. Clin Immunol 2002;103:303-8.
13. Artlett CM, Cox LA, Jimenez SA. Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw alleles. Arthritis Rheum 2000;43:1062-7.
14. Artlett CM, Miller FW, Rider LG. Persistent maternally derived peripheral microchimerism is associated with the juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) 2001;40:1-6.
15. Zhong XY, Burk MR, Troeger C, Kang A, Holzgreve W, Hahn S. Fluctuation of maternal and fetal free extracellular circulatory DNA in maternal plasma. Obstet Gynecol 2000;96:991-6.
16. Hahn S, Zhong XY, Burk MR, Troeger C, Holzgreve W. Multiplex and real-time quantitative PCR on fetal DNA in maternal plasma: a comparison with fetal cells isolated from maternal blood. Ann N Y Acad Sci 2000;906:148-52.
17. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993;41:119-34.
18. Nepom GT. Class II antigens and disease susceptibility. Annu Rev Med 1995;46:17-25.
19. Cox LA, Ramos RC, Dennis TN, Jimenez SA, Smith JB, Artlett CM. Detection of microchimeric cells in the peripheral blood of non-pregnant women is enhanced by magnetic cell sorting prior to PCR. Clin Chem 2003;49:309-12.